CIK 0001661181
- Accelerated filer
Organogenesis Holdings Inc.
Sign in to watch- Ticker
- ORGO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 781-575-0775
- Business address
- 85 DAN ROAD, CANTON, MA, 02021
- Former names
- Avista Healthcare Public Acquisition Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 81 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-15 | Montecalvo Antonio S. VP Health Policy & Contracting | Grant or award | +14,383 | 83,939 | ||
| 2022-02-15 | Montecalvo Antonio S. VP Health Policy & Contracting | Grant or award · Stock Option (Right to Buy) | +34,112 | 34,112 | ||
| 2022-02-15 | Grow Brian Chief Commercial Officer | Grant or award | +45,143 | 89,715 | ||
| 2022-02-15 | Grow Brian Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +107,063 | 107,063 | ||
| 2022-02-15 | Bilbo Patrick Chief Operating Officer | Grant or award | +52,926 | 186,596 | ||
| 2022-02-15 | Bilbo Patrick Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +125,522 | 125,522 | ||
| 2022-02-15 | Freedman Lori VP and General Counsel | Grant or award | +41,843 | 75,594 | ||
| 2022-02-15 | Freedman Lori VP and General Counsel | Grant or award · Stock Option (Right to Buy) | +99,236 | 99,236 | ||
| 2022-02-15 | Francisco David Chief Financial Officer | Grant or award | +40,348 | 56,709 | ||
| 2022-02-15 | Francisco David Chief Financial Officer | Shares withheld for taxes | −1,876 | $8.03 | $15K | 54,833 |
| 2022-02-15 | Francisco David Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +95,692 | 95,692 | ||
| 2022-02-15 | Gillheeney Gary S. President and CEO | Grant or award | +280,199 | 412,116 | ||
| 2022-02-15 | Gillheeney Gary S. President and CEO | Grant or award · Stock Option (Right to Buy) | +664,532 | 664,532 | ||
| 2021-12-28 | RED Holdings, LLC 10% owner | Gift | −4,661,129 | 59,448,027 | ||
| 2021-12-28 | RED Holdings, LLC 10% owner | Gift | +4,661,129 | 59,448,027 | ||
| 2021-12-28 | RED Holdings, LLC 10% owner | Gift | −7,392,328 | 59,448,027 | ||
| 2021-12-28 | RED Holdings, LLC 10% owner | Gift | +7,392,328 | 59,448,027 | ||
| 2021-12-28 | Albert Erani Family Trust dated 12/29/2012 10% owner | Gift | −4,661,129 | 59,448,027 | ||
| 2021-12-28 | Albert Erani Family Trust dated 12/29/2012 10% owner | Gift | +4,661,129 | 59,448,027 | ||
| 2021-12-28 | Albert Erani Family Trust dated 12/29/2012 10% owner | Gift | −7,392,328 | 59,448,027 |
Page 19 of 24 · 473 trades